NASDAQ:ALMS News 6 December 2025

Alumis Inc stock (ALMS) jumps again on Nasdaq — here’s what’s driving the move and what comes next

Alumis shares rose 6.7% to $26.15 by midday Monday, with trading volume reaching about 530,000. The move followed gains in biotech indexes and came ahead of the company’s upcoming quarterly update. No new company news was released. Investors remain focused on the psoriasis drug filing timeline and recent clinical trial results.

2 February 2026

Nasdaq·NASDAQ:ALMS·Stock Market

Alumis (ALMS) stock jumps as insider filings show $17 buys — what investors are watching next

Alumis Inc shares rose about 9% to $24.11 by midday Wednesday after insider filings showed directors Srinivas Akkaraju and James B. Tananbaum bought nearly 1 million shares at $17 each last week. The moves followed positive Phase 3 results for the company’s psoriasis drug envudeucitinib and a $345 million stock offering.

14 January 2026

NASDAQ:ALMS·Stock Market

Alumis stock jumps 129% after Phase 3 psoriasis data; ALMS hits new 52-week high

Alumis shares surged 129% Tuesday after its psoriasis pill, envudeucitinib, met all main goals in Phase 3 trials. About 65% of patients reached PASI 90 and over 40% achieved complete clearance at week 24. The company reported no new safety concerns and plans to file for FDA approval in the second half of 2026. Traders are watching durability and safety data.

6 January 2026

NASDAQ:ALMS·Pharmaceuticals·Stock Market

Biggest Stock Gainers Today (December 5, 2025): TGL, SMX, WHLR, DBRG, TORO, PRAX and RBRK Lead a Volatile Session

The U.S. stock market logged another upbeat session on Friday, December 5, 2025, with the S&P 500, Nasdaq 100 and Dow all edging higher. But beneath the index-level moves, a cluster of highly volatile small caps, high‑growth tech names and a few mid‑caps stole the show with spectacular double‑ and even triple‑digit gains. StockAnalysis+1 Below is a breakdown of the biggest stock gainers today, why they moved, and what recent forecasts and analyst commentary suggest about their outlooks. All data and price moves refer to the U.S. session on December 5, 2025, unless otherwise noted. Top 10 Biggest U.S. Stock Gainers Today (By

6 December 2025

NASDAQ:ALMS·NASDAQ:LICN·NASDAQ:PRAX·NASDAQ:SMX·NASDAQ:SPHL·NASDAQ:TDIC·NASDAQ:TGL·NASDAQ:TORO·NASDAQ:WAI·NASDAQ:WHLR·NYSE:DBRG·NYSE:RBRK·Stock Market

Applied Materials stock jumps 6% into a packed week — what matters before Monday

7 February 2026

Applied Materials shares jumped 6.1% to $322.51 Friday as chip stocks rebounded, ending the week 6% below their 52-week high. Investors await Applied’s earnings report on Feb. 12 and new U.S. economic data, with export controls and China exposure still seen as key risks.

Hermes share price holds near €2,055 into results week — what investors watch next

7 February 2026

Hermès shares closed at €2,055 in Paris on Friday, up 0.3%. The company will report 2025 annual results on Feb. 12, with investors focused on demand, currency effects, and management’s outlook. The CAC 40 ended higher, while Stellantis tumbled over 25%. European companies are forecast to post a 3.1% drop in fourth-quarter earnings.

RTX stock faces Pentagon payout curb list next week as dividend stays in play

7 February 2026

RTX closed at $198.66 Friday, up 1.4%, after declaring a 68-cent quarterly dividend payable March 19. The Pentagon is expected to name defense contractors early next week that could face limits on dividends and buybacks under a Trump order. RTX’s Raytheon unit has been singled out as “least responsive.” Companies named would have 15 days to submit remediation plans.

Kweichow Moutai (600519) stock price slides 2.6% — what to know before China markets reopen

7 February 2026

Kweichow Moutai Class A shares fell 2.6% to 1,515.01 yuan at Friday’s close in Shanghai, with about 7.9 million shares traded. A 2,500-share block trade matched the closing price. Liquor stocks broadly declined, while wholesale prices for Feitian Moutai labels rose Saturday. Investors await China’s February 11 inflation data as the next key event.

NASDAQ:ALMS News 6 December 2025 - 2 February 2026

Alumis Inc stock (ALMS) jumps again on Nasdaq — here’s what’s driving the move and what comes next

Alumis (ALMS) stock jumps as insider filings show $17 buys — what investors are watching next

Alumis stock jumps 129% after Phase 3 psoriasis data; ALMS hits new 52-week high

Biggest Stock Gainers Today (December 5, 2025): TGL, SMX, WHLR, DBRG, TORO, PRAX and RBRK Lead a Volatile Session

Stock Market Today

Applied Materials stock jumps 6% into a packed week — what matters before Monday

Hermes share price holds near €2,055 into results week — what investors watch next

RTX stock faces Pentagon payout curb list next week as dividend stays in play

Kweichow Moutai (600519) stock price slides 2.6% — what to know before China markets reopen